Medigene AG sell geldnutzer
Start price
24.06.23
/
60%
€1.87
Target price
24.06.24
€1.00
Performance (%)
-16.62%
Price
03.05.24
€1.56
Summary
This prediction is currently active. The prediction for Medigene AG shows a convincing performance of -16.62%. This prediction currently runs until 24.06.24. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Medigene AG | 2.303% | 2.303% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
According to geldnutzer what are the pros and cons of Medigene AG for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is not important
high free float
Higher risks for its business
Little known brand
Business model of the past or high risk
Little Investments for future growth
Little innovation
Below average Marketposition
Significant cyclical dependencies
Comments by geldnutzer for this prediction
In the thread Medigene AG diskutieren
Sell mit Kursziel 1,0